Skip to main content
Year archive

Aegon N.V. — 2019 filings

All 330 regulatory filings released by Aegon N.V. (AGN) in 2019, sourced directly from the official regulator.

330 Filings
2019 Period
2019 filings (330)
Filing Released Lang
Aegon reinsures longevity exposure in the Netherlands
Capital/Financing Update
2019-12-19 English
Aegon reinsures longevity exposure in the Netherlands
Capital/Financing Update
2019-12-19 English
Aegon: Translating growth opportunities into valuable businesses
Report Publication Announcement
2019-12-12 Dutch
Aegon: Translating growth opportunities into valuable businesses
Investor Presentation
2019-12-12 English
Aegon completes share buyback program
Transaction in Own Shares
2019-11-11 Dutch
Aegon completes share buyback program
Transaction in Own Shares
2019-11-11 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-10-28 English
Form 8.3 - Allergan plc
Director's Dealing
2019-10-25 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-10-25 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-10-25 English
Form 8.3 - Allergan plc
Director's Dealing
2019-10-24 English
Form 8.3 - AbbVie Inc.
Director's Dealing
2019-10-24 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-10-24 English
Aegon calls USD 1 billion in perpetual capital securities
Capital/Financing Update
2019-10-24 English
Form 8.3 - Allergan plc
Director's Dealing
2019-10-23 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-10-23 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-10-23 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-10-22 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Regulatory Filings
2019-10-22 English
Form 8.3 - Allergan Plc
Director's Dealing
2019-10-22 English
Form 8.3 - AbbVie. Inc
Major Shareholding Notification
2019-10-22 English
Form 8.3 - Allergan plc
Director's Dealing
2019-10-21 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-10-21 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-10-21 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
M&A Activity
2019-10-21 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-10-18 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-10-18 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-10-18 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Major Shareholding Notification
2019-10-18 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-10-17 English
Form 8.3 - Allergan plc
Director's Dealing
2019-10-17 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-10-17 English
CORRECTING AND REPLACING Aegon prices USD 925 million of Tier 2 subordinated notes
Capital/Financing Update
2019-10-17 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-10-16 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-10-16 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-10-16 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-10-16 English
Aegon prices USD 925 million of Tier 2 subordinated notes
Capital/Financing Update
2019-10-16 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-10-15 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-10-15 English
Form 8.3 - Allergan plc
Director's Dealing
2019-10-15 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-10-15 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-10-14 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-10-14 English
Form 8.3 - Allergan plc
Director's Dealing
2019-10-14 English
Form 8.3 - AbbVie Inc
Director's Dealing
2019-10-14 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Regulatory Filings
2019-10-11 English
Form 8.3 - Allergan plc
Director's Dealing
2019-10-11 English
Form 8.3 - AbbVie Inc
Director's Dealing
2019-10-11 English
Thomas Wellauer to join Aegon’s Supervisory Board; Robert Dineen steps down
Board/Management Information
2019-10-11 Dutch
Thomas Wellauer to join Aegon’s Supervisory Board; Robert Dineen steps down
Board/Management Information
2019-10-11 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-10-10 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Regulatory Filings
2019-10-09 English
Form 8.3 - Allergan plc
Director's Dealing
2019-10-09 English
Form 8.3 - AbbVie Inc
Director's Dealing
2019-10-09 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-10-08 English
Form 8.3 - Allergan plc
Director's Dealing
2019-10-08 English
Form 8.3 - AbbVie Inc
M&A Activity
2019-10-08 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan plc
Director's Dealing
2019-10-07 English
Form 8.3 -Allergan plc
Major Shareholding Notification
2019-10-07 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-10-07 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-10-07 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-10-04 English
Form 8.3 - Allergan plc
Regulatory Filings
2019-10-04 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-10-04 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-10-04 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-10-03 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-10-03 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-10-03 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Regulatory Filings
2019-10-03 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-10-02 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-10-01 English
Form 8.3 - Allergan Plc
Major Shareholding Notification
2019-10-01 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
M&A Activity
2019-10-01 English
Form 8.3 - AbbVie. Inc
Major Shareholding Notification
2019-10-01 English
Form 8.3 - Allergan Plc
Director's Dealing
2019-09-30 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-09-30 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-09-30 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-09-27 English
Form 8.3 - Allergan plc
Director's Dealing
2019-09-26 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-09-26 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Regulatory Filings
2019-09-26 English
Form 8.3 - Allergan plc
Director's Dealing
2019-09-25 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-09-25 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Regulatory Filings
2019-09-25 English
Form 8.3 - Allergan plc
Director's Dealing
2019-09-24 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-09-24 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Major Shareholding Notification
2019-09-24 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Regulatory Filings
2019-09-23 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-09-23 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-09-23 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-09-23 English
Aegon establishes international division and intends to appoint Maarten Edixhoven to its Management Board
Management Reports
2019-09-23 English
Aegon establishes international division and intends to appoint Maarten Edixhoven to its Management Board
Board/Management Information
2019-09-23 English
Form 8.3 - Allergan Plc
Director's Dealing
2019-09-20 English
Form 8.3 - AbbVie. Inc
Director's Dealing
2019-09-20 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-09-20 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-09-20 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-09-19 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-09-19 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-09-19 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-09-18 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-09-18 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-09-18 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-09-18 English
Aegon announces purchase of shares to neutralize 2019 interim stock dividend
Notice of Dividend Amount
2019-09-18 English
Aegon announces purchase of shares to neutralize 2019 interim stock dividend
Transaction in Own Shares
2019-09-18 Dutch
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-09-17 English
Form 8.3 - Allergan plc
Director's Dealing
2019-09-17 English
Form 8.3 - AbbVie Inc
Director's Dealing
2019-09-17 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
M&A Activity
2019-09-17 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-09-16 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-09-16 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-09-16 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-09-16 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-09-13 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-09-13 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-09-13 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-09-13 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Regulatory Filings
2019-09-12 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-09-10 English
Form 8.3 - Allergan plc
Director's Dealing
2019-09-10 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-09-10 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Regulatory Filings
2019-09-10 English
Mike Holliday-Williams to succeed Adrian Grace as CEO of Aegon UK
Board/Management Information
2019-09-10 English
Mike Holliday-Williams to succeed Adrian Grace as CEO of Aegon UK
Board/Management Information
2019-09-10 Dutch
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-09-09 English
Form 8.3 - Allergan plc
Director's Dealing
2019-09-09 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-09-09 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Major Shareholding Notification
2019-09-09 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-09-05 English
Form 8.3 - Allergan plc
Director's Dealing
2019-09-05 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-09-05 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-09-05 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-09-04 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-09-04 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-09-04 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-09-04 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Regulatory Filings
2019-09-03 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-09-02 English
Form 8.3 - Allergan Plc
Director's Dealing
2019-09-02 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan plc
Director's Dealing
2019-09-02 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-09-02 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan plc
Director's Dealing
2019-08-29 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-08-29 English
Form 8.3 - AbbVie Inc
M&A Activity
2019-08-29 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-08-29 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan plc
Director's Dealing
2019-08-28 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-08-28 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-08-28 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Declaration of Voting Results & Voting Rights Announcements
2019-08-28 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan plc
Director's Dealing
2019-08-27 English
Form 8.3 - Allergan plc
Director's Dealing
2019-08-27 English
Form 8.3 - AbbVie Inc
Director's Dealing
2019-08-27 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-08-27 English
Form 8.3 -Allergan plc
Director's Dealing
2019-08-26 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan plc
M&A Activity
2019-08-26 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-08-26 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-08-26 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-08-22 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan plc
M&A Activity
2019-08-22 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Regulatory Filings
2019-08-22 English
Form 8.3 - Allergan Plc
Director's Dealing
2019-08-21 English
Form 8.3 - AbbVie. Inc
Director's Dealing
2019-08-21 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan plc
Major Shareholding Notification
2019-08-21 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-08-21 English
Form 8.3 - Allergan Plc
Director's Dealing
2019-08-20 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-08-20 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan plc
Director's Dealing
2019-08-20 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-08-20 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-08-19 English
Form 8.3 - AbbVie Inc
Director's Dealing
2019-08-19 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Major Shareholding Notification
2019-08-19 English
Interim / Quarterly Report 2019
Interim / Quarterly Report H1 2019
2019-08-19 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan plc
Regulatory Filings
2019-08-16 English
Form 8.3 - Allergan plc
Director's Dealing
2019-08-16 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-08-16 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-08-16 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan plc
Director's Dealing
2019-08-15 English
Form 8.3 - Allergan Plc
M&A Activity
2019-08-15 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-08-15 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-08-15 English
Aegon reports first half 2019 results
Earnings Release H1 2019
2019-08-15 English
Aegon reports first half 2019 results
Earnings Release H1 2019
2019-08-15 English
Form 8.3 - Allergan plc
M&A Activity
2019-08-14 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan plc
Regulatory Filings
2019-08-14 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-08-14 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
M&A Activity
2019-08-14 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan plc
Major Shareholding Notification
2019-08-13 English
Form 8.3 -Allergan plc
Major Shareholding Notification
2019-08-13 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-08-13 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-08-13 English
Form 8.3 -AbbVie Inc
Major Shareholding Notification
2019-08-12 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-08-12 English
Lard Friese to succeed Alex Wynaendts as Aegon’s CEO
Board/Management Information
2019-08-12 English
Lard Friese to succeed Alex Wynaendts as Aegon’s CEO
Board/Management Information
2019-08-12 English
Form 8.3 - Allergan Plc
Major Shareholding Notification
2019-08-09 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-08-09 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Regulatory Filings
2019-08-09 English
Form 8.3 -Allergan plc
Director's Dealing
2019-08-08 English
Form 8.3 -AbbVie Inc
Major Shareholding Notification
2019-08-08 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-08-08 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-08-07 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-08-07 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-08-07 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Major Shareholding Notification
2019-08-07 English
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
Director's Dealing
2019-08-06 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-08-06 English
Form 8.3 - Allergan Plc.
Director's Dealing
2019-08-06 English
Form 8.3 - Abb
Director's Dealing
2019-08-06 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-08-05 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-08-05 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Regulatory Filings
2019-08-05 English
Aegon completes share buyback program
Transaction in Own Shares
2019-08-05 English
Aegon completes share buyback program
Transaction in Own Shares
2019-08-05 Dutch
Form 8.3 -Allergan plc
Major Shareholding Notification
2019-08-01 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-08-01 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-08-01 English
Form 8.3 - Allergan
Major Shareholding Notification
2019-07-31 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-07-31 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Major Shareholding Notification
2019-07-31 English
Form 8.3 - Allergan Plc
Major Shareholding Notification
2019-07-30 English
Form 8.3 - Allergan Plc
Director's Dealing
2019-07-30 English
Form 8.3 - Abbvie Inc.
M&A Activity
2019-07-30 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-07-30 English
Form 8.3 - Allergan Plc
Director's Dealing
2019-07-29 English
Form 8.3 - Allergan Plc
Major Shareholding Notification
2019-07-29 English
Form 8.3 - Abbvie Inc
Major Shareholding Notification
2019-07-29 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
M&A Activity
2019-07-29 English
Form 8.3 - Allergan PLC
Director's Dealing
2019-07-26 English
Form 8.3 - Allergan Plc
M&A Activity
2019-07-26 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-07-26 English
Form 8.3 - Allergan Plc
Major Shareholding Notification
2019-07-25 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-07-25 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Major Shareholding Notification
2019-07-25 English
Form 8.3 - Allergan Plc
Major Shareholding Notification
2019-07-24 English
Form 8.3 - Abbvie Inc
Director's Dealing
2019-07-24 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-07-24 English
Form 8.3 - Allergan Plc
Major Shareholding Notification
2019-07-23 English
Form 8.3 - Abbvie Inc
Major Shareholding Notification
2019-07-23 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-07-23 English
Form 8.3 - Allergan Plc
Regulatory Filings
2019-07-22 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-07-22 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-07-22 English
Form 8.3 - Allergan plc
Director's Dealing
2019-07-19 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-07-19 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
M&A Activity
2019-07-19 English
Form 8.3 - Allergan PLC
Director's Dealing
2019-07-18 English
Form 8.3 - Allergan plc
Director's Dealing
2019-07-18 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-07-18 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Major Shareholding Notification
2019-07-18 English
Form 8.3 - Allergan Plc
Major Shareholding Notification
2019-07-17 English
Form 8.3 - Allergan plc
Director's Dealing
2019-07-17 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-07-17 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
M&A Activity
2019-07-17 English
Form 8.3 - Allergan Plc
Major Shareholding Notification
2019-07-16 English
Form 8.3 - Allergan plc
Director's Dealing
2019-07-16 English
Form 8.3 - AbbVie Inc.
M&A Activity
2019-07-16 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-07-16 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-07-15 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-07-15 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
M&A Activity
2019-07-15 English
Form 8.3 - Allergan plc
Regulatory Filings
2019-07-12 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-07-12 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Major Shareholding Notification
2019-07-12 English
Form 8.3 - Allergan Plc
M&A Activity
2019-07-11 English
Form 8.3 - Allergan plc
Director's Dealing
2019-07-11 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-07-11 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Regulatory Filings
2019-07-11 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-07-10 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-07-10 English
Form 8.3 - Allergan Plc
Director's Dealing
2019-07-10 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-07-10 English
FRN Variable Rate Fix
Interest Rate Update/Notice
2019-07-09 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-07-09 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Major Shareholding Notification
2019-07-09 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-07-09 English
Form 8.3 - Allergan Plc
Director's Dealing
2019-07-08 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-07-08 English
Form 8.3 - AbbVie Inc
Major Shareholding Notification
2019-07-08 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Major Shareholding Notification
2019-07-08 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
M&A Activity
2019-07-05 English
Form 8.3 - Allergan Plc
Director's Dealing
2019-07-04 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Regulatory Filings
2019-07-04 English
Form 8.3 - Allergan plc
Director's Dealing
2019-07-04 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-07-04 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-07-03 English
Form 8.3 - Allergan Plc
Major Shareholding Notification
2019-07-03 English
Form 8.3 - AbbVie Inc
Director's Dealing
2019-07-03 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-07-03 English
Form 8.3 - ALLERGAN PLC
Director's Dealing
2019-07-02 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-07-02 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-07-02 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-07-02 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-07-01 English
Form 8.3 - Allergan plc
Major Shareholding Notification
2019-07-01 English
Form 8.3 - AbbVie Inc.
Major Shareholding Notification
2019-07-01 English
Form 8.3 - Allergan Plc
Major Shareholding Notification
2019-07-01 English
Invesco ltd: Form 8.3 - Allergan PLC
Director's Dealing
2019-07-01 English
Form 8.3 - Allergan PLC
Major Shareholding Notification
2019-06-27 English
State Street Global Advisors Ireland Limited : Form 8.3 - Allergan plc
Major Shareholding Notification
2019-06-27 English
Invesco ltd: Form 8.3 - Allergan PLC
M&A Activity
2019-06-27 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Director's Dealing
2019-06-27 English
State Street Global Advisors Ireland Limited : Form 8.3 - Allergan plc
Major Shareholding Notification
2019-06-26 English
Form 8.3 -Allergan PLC
Major Shareholding Notification
2019-06-26 English
Invesco ltd: Form 8.3 - Allergan PLC
Director's Dealing
2019-06-26 English
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Major Shareholding Notification
2019-06-26 English
State Street Global Advisors Ireland Limited : Form 8.3 - Allergan plc
Director's Dealing
2019-06-25 English
Aegon announces purchase of shares to neutralize 2018 final stock dividend
Notice of Dividend Amount
2019-06-19 English
Aegon announces purchase of shares to neutralize 2018 final stock dividend
Notice of Dividend Amount
2019-06-19 Dutch
Aegon Bank successfully prices inaugural EUR 500 million Senior Non-Preferred notes
Capital/Financing Update
2019-06-17 English
Aegon Bank successfully prices inaugural EUR 500 million Senior Non-Preferred notes
Capital/Financing Update
2019-06-17 English
Bas NieuweWeme appointed as CEO of Aegon Asset Management
Board/Management Information
2019-05-29 English
Bas NieuweWeme appointed as CEO of Aegon Asset Management
Board/Management Information
2019-05-29 English
Aegon: Annual Meeting of Shareholders adopts all resolutions
AGM Information
2019-05-17 English
Aegon: Annual Meeting of Shareholders adopts all resolutions
AGM Information
2019-05-17 Dutch
Aegon to divest stake in partnership with Sony Life in Japan
M&A Activity
2019-05-17 English
Aegon to divest stake in partnership with Sony Life in Japan
M&A Activity
2019-05-17 Dutch
Aegon calls USD 500 million in perpetual capital securities
Capital/Financing Update
2019-05-07 English
Aegon publishes agenda for 2019 Annual General Meeting
AGM Information
2019-04-05 English
Aegon publishes agenda for 2019 Annual General Meeting
AGM Information
2019-04-05 English
Aegon prices EUR 500 million Restricted Tier 1 securities
Capital/Financing Update
2019-03-29 English
Aegon prices EUR 500 million Restricted Tier 1 securities
Capital/Financing Update
2019-03-29 English
Aegon publishes 2018 Integrated Annual Report
Report Publication Announcement FY 2018
2019-03-22 Dutch
Aegon publishes 2018 Integrated Annual Report
Report Publication Announcement
2019-03-22 English
Annual Report 2018
Annual Report FY 2018
2019-03-22 English
Aegon to grow capital generation and dividends
Earnings Release H2 2018
2019-02-14 English
Aegon to grow capital generation and dividends
Earnings Release H2 2018
2019-02-14 English
Aegon reports second half 2018 results
Earnings Release H2 2018
2019-02-14 English
Aegon reports second half 2018 results
Earnings Release H2 2018
2019-02-14 English